Singleron to Launch Tensor at Festival of Genomics, Setting New Standards in Single Cell Sequencing Automation 21.01.20252’Cologne, Germany – January 21, 2025 – Singleron Biotechnologies will introduce the Tensor High Throughput Single Cell Library Processing System, the first fully automated instrument for single cell sequencing library preparation, from cell suspension to sequencing-ready library, to address the increased needs for throughput and automation in the field. Tensor enables the preparation of up to 32 single cell sequencing libraries of up to 3 million cells in a single run, reducing hands-on time by 90% and completing the process in a single workday.Tensor: A New Standard in High Throughput Single Cell Sequencing AutomationTensor addresses key challenges in single cell workflows, including procedural complexity and manual workload. Singleron’s SCOPE-Adaptor technology not only empowers its Tensor system, but also works as a nimble module that can be integrated in the most commonly used liquid handler systems customers already have in their laboratories.End-to-End Automation SolutionsWhile Tensor automates the critical steps of single cell partitioning and library preparation, it complements Singleron’s existing portfolio, which includes automation solutions for tissue dissociation, cloud-based data analysis, and data interpretation. Together, these products automate and standardize the comprehensive end-to-end workflow for single cell sequencing—from tissue to data, making single cell sequencing ready for clinical translations and applications.Live Product Launch at Festival of Genomics, LondonAt the Festival of Genomics in London, January 29-30 2025, Singleron will present the concepts of Tensor and its Early Access Program.Join us for the live event at 4:00 PM on January 29 at booth #187. To register for the event, visit https://singleron.bio/news/single-cell-workflow-automation-fog2025/.About Singleron BiotechnologiesFounded in 2018, Singleron Biotechnologies is dedicated to advancing human health through pioneering single cell multi-omics solutions. With a portfolio that includes instruments, reagents, bioinformatics software, and a comprehensive single cell knowledgebase, Singleron operates globally with offices and facilities in Germany, Singapore, the USA, and China. Singleron products are used in over 4,000 laboratories worldwide, spanning hospitals, research institutes, and pharmaceutical companies. For more information, visit www.singleron.bioCheck out our latest news and events Learn more 25.01.10 Transform Single Cell Workflow with Automation at FoG2025, London Tired of all the pipetting in your single cell experiments? We’ve designed a solution to help you do more, faster, and with greater precision. Join… Read more 24.11.20 Singleron Partners with TOMY to Expand Single Cell Offerings in Japan Cologne, November 20, 2024 – Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co.,… Read more 24.10.28 B2B-RARE: Bench to Bedside – Rapid Diagnosis and Personalized Treatment of Rare Neuromuscular Diseases For the German version of the article, see here. NRW, 28th October 2024 – More than 400 genetically determined neuromuscular diseases (NME) are rare diseases…. Read more
25.01.10 Transform Single Cell Workflow with Automation at FoG2025, London Tired of all the pipetting in your single cell experiments? We’ve designed a solution to help you do more, faster, and with greater precision. Join… Read more
24.11.20 Singleron Partners with TOMY to Expand Single Cell Offerings in Japan Cologne, November 20, 2024 – Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co.,… Read more
24.10.28 B2B-RARE: Bench to Bedside – Rapid Diagnosis and Personalized Treatment of Rare Neuromuscular Diseases For the German version of the article, see here. NRW, 28th October 2024 – More than 400 genetically determined neuromuscular diseases (NME) are rare diseases…. Read more